LENZ Therapeutics, Inc.

United States
152 Total Employees
Year Founded: 2017
LENZ Therapeutics, Inc. is a late-stage biopharmaceutical company developing and commercializing ophthalmic therapies to improve vision. Its lead product, VIZZ (aceclidine ophthalmic solution), is a once-daily eye drop for presbyopia aimed at restoring near vision for hours. The company is commercially active in the U.S. with ongoing international regulatory and partnership efforts.

LENZ Therapeutics, Inc. Offices

Hybrid Workspace

Employees engage in a combination of remote and on-site work.

Typical time on-site:
United States